
How Traditional Chinese Medicine can Help with Insomnia?
How Traditional Chinese Medicine approaches insomnia: pattern differentiation, herbal formulae like Suanzaoren Decoction and what the clinical evidence shows.
A Multi-Target, Syndrome-Specific, and Evidence-Informed Approach
Abstract
Insomnia is a prevalent condition with substantial personal and societal costs. While conventional pharmacotherapy offers symptomatic relief, concerns regarding tolerance, dependence, and residual daytime impairment persist. Traditional Chinese Medicine (TCM) presents a conceptually distinct and increasingly evidence-supported alternative. This paper examines how TCM approaches insomnia through three interconnected dimensions: its theoretical framework of pattern differentiation, the pharmacological actions of representative herbal formulae, and emerging clinical and mechanistic evidence. TCM does not treat insomnia as a uniform disorder but as a manifestation of underlying systemic imbalance, most commonly involving the Heart, Liver, Spleen, and Kidney. Formulae such as Suanzaoren Decoction and Bailemian Capsule demonstrate measurable efficacy in improving sleep quality, with network meta-analyses indicating that certain Chinese patent medicines may outperform Western drugs or placebo in specific domains . Mechanistically, TCM formulae operate through multi-target pathways, modulating GABAergic, serotonergic, and orexinergic systems while regulating circadian clock gene expression . The integration of TCM with conventional care also appears to reduce adverse events compared with Western medication alone . However, methodological limitations in existing trials warrant cautious interpretation. TCM’s contribution to insomnia management lies less in replacing conventional hypnotics than in offering a holistic, individualized, and potentially safer long-term strategy.
1. Introduction
Insomnia affects a substantial proportion of adults worldwide and is associated with impaired quality of life, increased risk of cardiometabolic disease, and significant economic burden. Conventional treatment—particularly benzodiazepine receptor agonists and non-benzodiazepine hypnotics—remains the mainstay of pharmacotherapy, yet its limitations are well recognized: tolerance, dependence, withdrawal rebound, and next-day sedation. These shortcomings have prompted sustained interest in complementary and integrative approaches.
Traditional Chinese Medicine (TCM) has treated sleep disorders for over two millennia under the rubric of bumei (不寐), or “inability to sleep.” Unlike the symptom-focused logic of conventional hypnotics, TCM constructs insomnia as a systemic dysregulation—a failure of the shen (spirit) to settle due to deficiency, excess, or stagnation in specific organ systems. This framework generates a therapeutic logic that is inherently multi-target and individualized.
This paper argues that TCM’s contribution to insomnia treatment is best understood not as a simple alternative to hypnotics but as a parallel therapeutic paradigm with distinct strengths: pattern-based personalization, multi-component pharmacology, and a favorable safety profile when appropriately applied. The discussion proceeds through three sections: the theoretical and diagnostic framework, the evidence for representative formulae, and the pharmacological mechanisms that underpin their effects.
2. The Theoretical Framework: Pattern Differentiation as Therapeutic Logic
2.1 Insomnia as Systemic Imbalance
In TCM theory, sleep depends on the harmonious circulation of qi, blood, and yin-yang across the organ systems. The Heart houses the shen; when Heart blood or yin is deficient, the shen lacks anchorage and sleep becomes restless or elusive. The Liver governs the free flow of qi; Liver qi stagnation generates heat that disturbs the Heart. The Spleen produces blood and qi; Spleen deficiency leaves the Heart unsupplied. The Kidney stores essence and anchors yang; Kidney yin deficiency allows deficient fire to harass the upper body.
This produces a classification of insomnia into distinct patterns—Heart-Spleen deficiency, Liver-qi stagnation with heat, Heart-Kidney disharmony, phlegm-heat harassing the interior, and others. The clinical significance is that two patients with identical Pittsburgh Sleep Quality Index (PSQI) scores may receive entirely different herbal formulae based on tongue, pulse, and symptom constellation.
2.2 Implications for Treatment
Pattern differentiation has practical consequences. A patient with Heart-Spleen deficiency—characterized by difficulty falling asleep, palpitations, fatigue, and a pale tongue—receives a formula such as Guipi Tang that tonifies qi and blood. A patient with Liver-qi stagnation and heat—irritability, dream-disturbed sleep, bitter taste, a red tongue with yellow coating—receives a formula such as Dan Zhi Xiaoyao San that drains Liver fire and harmonizes qi. This stands in contrast to the “one drug fits all” logic of hypnotic prescribing and may partly explain why TCM trials often report improvements in secondary outcomes such as fatigue, irritability, and quality of life alongside sleep parameters .
3. Evidence for Representative Formulae
3.1 Suanzaoren Decoction
Suanzaoren Tang (Sour Jujube Seed Decoction) is among the most extensively studied TCM formulae for insomnia. First recorded in the Jin Gui Yao Lue nearly two millennia ago, it is classically indicated for insomnia with irritability and a sensation of heat—a presentation corresponding to deficient Liver blood with internal heat.
A recent longitudinal study comparing Suanzaoren Decoction with estazolam in chronic insomnia patients found that the herbal formula not only improved self-reported sleep quality but also produced measurable changes in functional connectivity within the sensorimotor network, suggesting a central nervous system mechanism beyond mere sedation . Meta-analytic evidence indicates that the decoction significantly enhances quality of life in chronic insomnia patients while reducing treatment-related adverse effects . A separate trial in perimenopausal insomnia demonstrated that Zhichi Suanzaoren Decoction improved both sleep and anxiety symptoms without producing rebound insomnia upon discontinuation—a clinically meaningful advantage over conventional hypnotics .
3.2 Chinese Patent Medicines: Network Meta-Analytic Evidence
A comprehensive network meta-analysis of 109 randomized controlled trials involving 11,488 participants evaluated 45 Chinese patent medicines for primary insomnia . The analysis found that Chinese patent medicines, as a class, were superior to both Western drugs and placebo on multiple sleep outcomes. Specific preparations—Shenqi Jiangya (SGJY), Shuqi Wenzhen (SQWWZ), and Tianmeng combined with benzodiazepines—were among the most effective for improving sleep quality. SQWWZ and Anshen Bunao (ASBN) were most likely to be optimal for prolonging subjective total sleep time and reducing subjective sleep onset latency .
These findings should be interpreted with appropriate caution: the included trials exhibited heterogeneity and variable methodological quality. Nevertheless, the scale of the evidence base—over one hundred randomized trials—argues against dismissing TCM as a mere placebo effect.
3.3 Add-On and Integrative Use
A particularly promising finding concerns the adjunctive use of TCM alongside conventional medication. A meta-analysis of 15 trials (1,547 participants) examining Bailemian Capsule found that combining the herbal preparation with sedating psychotropic drugs significantly reduced PSQI scores compared with psychotropic monotherapy. Critically, the combination also reduced the incidence of adverse events (RR = 0.29, 95% CI 0.17–0.50), indicating that TCM may allow for lower doses of conventional medication or mitigate its side effects . Similar patterns have been reported for Suanzaoren Decoction combined with antidepressants in depression comorbid with insomnia .
4. Pharmacological Mechanisms: Multi-Target Modulation
4.1 Neurotransmitter Regulation
Modern pharmacological research has begun to decode the mechanisms underlying TCM’s clinical effects. A study of Yixin Anshen Granules, an eight-herb formula, demonstrated that its sedative-hypnotic effects are mediated through modulation of multiple neurotransmitter systems: serotonergic (5-HT1A receptors), GABAergic (GABA A α1 receptors), and orexinergic (OX1 receptors) pathways. The formula shortened wake time and prolonged non-REM sleep in insomnia model rodents, while also improving sleep fragmentation . This multi-receptor profile contrasts with the single-target action of most conventional hypnotics and may explain the broader symptom improvements observed in clinical trials.
4.2 Circadian Clock Genes
Emerging evidence suggests that certain TCM interventions may influence circadian rhythm regulation at the molecular level. Suanzaoren Decoction and related formulae have demonstrated the capacity to modulate clock gene expression, potentially restoring disrupted circadian rhythms rather than simply forcing sedation . This is a mechanistically distinct proposition from GABA-A receptor potentiation and warrants further investigation.
4.3 Network Pharmacology and Synergistic Herb Pairs
A data-mining study of 104 classical prescriptions for insomnia identified Suanzaoren (Semen Ziziphi Spinosae) as the most frequently used herb, followed by licorice, ginseng, and Fushen . Network pharmacology analysis revealed that core herb pairs—such as Suanzaoren with Yuanzhi or Baiziren—act through the cAMP signaling pathway in concert with HIF-1, PI3K-Akt, and prolactin signaling pathways . This multi-pathway synergy is consistent with the traditional concept of peiwu (compatibility), in which herbs are combined not additively but to produce enhanced or modulated effects.
5. Critical Considerations and Limitations
Several caveats must temper enthusiasm. First, many clinical trials of TCM for insomnia originate from a single country and may exhibit publication bias favoring positive results. Second, blinding is inherently difficult with herbal decoctions that possess distinctive tastes and aromas, and many trials do not adequately report allocation concealment. Third, the network meta-analysis cited above, while comprehensive, noted high heterogeneity and risk of bias in the included studies .
A further conceptual issue concerns the relationship between TCM pattern differentiation and Western diagnostic categories. Most trials enroll patients based on DSM or ICSD criteria for insomnia disorder, yet administer a single formula to all participants—effectively bracketing the pattern-differentiation logic that constitutes TCM’s core theoretical claim. Trials that stratify by TCM pattern and compare pattern-specific versus generic prescribing would provide a more rigorous test of the paradigm itself.
Finally, safety requires ongoing attention. While TCM is often perceived as “natural” and therefore harmless, herbal preparations can interact with conventional drugs, and quality control of proprietary products varies. The finding that Bailemian Capsule reduced adverse events compared with psychotropic monotherapy is encouraging , but it does not license the assumption that all TCM is safe for all patients.
6. Conclusion
Traditional Chinese Medicine offers a coherent, mechanism-rich, and increasingly evidence-supported approach to insomnia that differs fundamentally from conventional hypnotic therapy. Its strengths lie in individualized pattern-based prescribing, multi-target pharmacology that addresses both sleep and comorbid symptoms, and a safety profile that appears favorable, particularly when used as an adjunct to conventional care. The evidence base, while imperfect, is substantial: over one hundred randomized trials of Chinese patent medicines, mechanistic studies identifying neurotransmitter and circadian targets, and clinical trials demonstrating improvements in sleep quality and quality of life.
The most productive framing is neither “TCM instead of Western medicine” nor “TCM as placebo.” Rather, TCM constitutes a distinct therapeutic strategy whose optimal role—whether as first-line treatment for mild insomnia, as an adjunct for patients partially responsive to conventional therapy, or as a harm-reduction strategy for those who cannot tolerate hypnotics—deserves rigorous, methodologically sophisticated investigation. For patients and clinicians alike, the question is not whether TCM “works” in some undifferentiated sense, but for whom, under what pattern diagnosis, and at what point in the therapeutic sequence.
